Patents by Inventor Sergei Bachurin

Sergei Bachurin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating schizophrenia
    Publication number: 20070225316
    Abstract: The present invention relates to methods and compositions useful for treating, preventing and/or delaying the onset and/or development of schizophrenia by administering a hydrogenated pyrido[4,3-b]indole, such as dimebon, or a pharmaceutically acceptable salt thereof, to an individual.
    Type: Application
    Filed: January 25, 2007
    Publication date: September 27, 2007
    Inventors: Sergei Bachurin, Vladimir Grigoriev, Margarita Morozova, Allan Beniashvili
  • Methods and compositions for slowing aging
    Publication number: 20070179174
    Abstract: The present invention provides a pharmacological agent based on derivatives of hydrogenated pyrido (4,3-b) indoles and uses thereof. Specifically, the invention provides a geroprotector in the series of hydrogenated pyrido (4,3-b) indoles (several derivatives), which can be used for slowing aging, prolonging lifespan of an individual or cells in an individual, and/or improving quality of life of an individual developing or having a risk of developing age-associated manifestations and/or pathologies.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 2, 2007
    Inventors: Sergei Bachurin, Vladimir Grigoriev
  • Agents for treating neurodegenerative disorders
    Publication number: 20060140866
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Application
    Filed: February 24, 2006
    Publication date: June 29, 2006
    Inventors: Nikolai Zefirov, Andrei Afanasiev, Svetlana Afanasieva, Sergei Bachurin, Sergei Tkachenko, Vladimir Grigoriev, Marina Jurovskaya, Valery Chetverikov, Elizaveta Bukatina, Irina Grigorieva
  • Neurodegenerative disorders
    Publication number: 20050096342
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Application
    Filed: December 2, 2004
    Publication date: May 5, 2005
    Applicant: Medivation, Inc.
    Inventors: Nikolai Zefirov, Andrei Afanasiev, Svetlana Afanasieva, Sergei Bachurin, Sergei Tkachenko, Vladimir Grigoriev, Marina Jurovskaya, Valery Chetverikov, Elizaveta Bukatina, Irina Grigorieva